TransMedics Group, Inc.TMDXNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank54
3Y CAGR-25.9%
5Y CAGR-1.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-25.9%/yr
vs +79.9%/yr prior
5Y CAGR
-1.1%/yr
Recent deceleration
Acceleration
-105.8pp
Decelerating
Percentile
P54
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.79% |
| Q3 2025 | 4.37% |
| Q2 2025 | 1.06% |
| Q1 2025 | -6.99% |
| Q4 2024 | 9.96% |
| Q3 2024 | -0.32% |
| Q2 2024 | 18.67% |
| Q1 2024 | 4.34% |
| Q4 2023 | 12.75% |
| Q3 2023 | 4.42% |
| Q2 2023 | 17.50% |
| Q1 2023 | 15.00% |
| Q4 2022 | 28.93% |
| Q3 2022 | -3.05% |
| Q2 2022 | 24.69% |
| Q1 2022 | 16.16% |
| Q4 2021 | 16.11% |
| Q3 2021 | 12.80% |
| Q2 2021 | 35.01% |
| Q1 2021 | 9.88% |
| Q4 2020 | 12.43% |
| Q3 2020 | -6.37% |
| Q2 2020 | -11.80% |
| Q1 2020 | 7.76% |
| Q4 2019 | -5.31% |
| Q3 2019 | 4.29% |
| Q2 2019 | 34.34% |
| Q1 2019 | 6.38% |
| Q4 2018 | 56.27% |
| Q3 2018 | -3.55% |
| Q2 2018 | 29.55% |
| Q1 2018 | 37.17% |
| Q4 2017 | -9.88% |
| Q3 2017 | -22.23% |
| Q3 2017 | 11.99% |
| Q2 2017 | 0.00% |